Tennessee House Bill HB1649

Tennessee 2025-2026 Regular Session

• Introduced: 1/14/26
• Refer: 1/21/26
• Refer: 3/4/26
• Refer: 3/18/26
• Refer: 3/25/26
• Refer: 3/31/26
• Engrossed: 4/8/26
• Enrolled: 4/23/26
• Passed: 5/7/26
• Chaptered: 5/15/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 33, Chapter 2; Title 38; Title 39; Title 50; Title 63 and Title 68, relative to Kratom.

Impact

If enacted, HB 1649 would significantly impact existing Tennessee laws concerning drug control and public health. By categorizing Kratom as a regulated substance, this bill could lead to increased legal consequences for individuals and suppliers involved with Kratom. Critics argue that blanket restrictions might deter responsible use and negate potential benefits of Kratom in certain contexts, such as pain management. The emphasis on testing and the inclusion of Kratom in legal frameworks aims to enhance public health responses to drug use crises, particularly as the opioid epidemic continues to affect many states.

Summary

House Bill 1649, also referred to as 'Matthew Davenport's Law', aims to regulate the use of Kratom, a substance derived from the mitragyna speciosa plant. The bill proposes strict penalties for the possession, manufacture, delivery, or sale of Kratom and establishes that testing for Kratom must be included in toxicology screenings in cases of suspected drug overdoses. Additionally, it mandates that county medical examiners test deceased individuals, whose suspected cause of death is drug-related, for the presence of Kratom. This legislation is designed to address growing concerns about the potential dangers associated with Kratom use.

Sentiment

The sentiment towards HB 1649 varies widely. Supporters, including various healthcare advocacy groups, argue that regulating Kratom is essential for protecting public health and curbing substance abuse. In contrast, opponents express concern that the bill may overreach, potentially criminalizing individuals who use Kratom responsibly. The general discourse surrounding the bill highlights a struggle between public safety interests and personal liberties regarding substance use, as well as debates over the efficacy of regulations versus education and treatment for substance abuse.

Contention

Notable points of contention surrounding HB 1649 include arguments over the medical benefits of Kratom and the potential legal repercussions for individuals and businesses. Proponents underscore the need for regulation given the associated risks of unregulated products, while detractors emphasize that such measures could inadvertently harm people who rely on Kratom for its alleged therapeutic effects. The legislation has sparked extensive discussion on how best to approach drug policy in the context of emerging substances that lack extensive research, raising questions about the balance between public health and individual rights.